Achieving equitable recruitment through inclusive protocol design: lessons learned from the ILANA study.

IF 2 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Trials Pub Date : 2025-07-01 DOI:10.1186/s13063-025-08936-1
Rosalie Hayes, Melanie Smuk, Bakita Kasadha, Nishat Halim, Vanessa Apea, Sara Paparini, Chloe M Orkin
{"title":"Achieving equitable recruitment through inclusive protocol design: lessons learned from the ILANA study.","authors":"Rosalie Hayes, Melanie Smuk, Bakita Kasadha, Nishat Halim, Vanessa Apea, Sara Paparini, Chloe M Orkin","doi":"10.1186/s13063-025-08936-1","DOIUrl":null,"url":null,"abstract":"<p><p>The importance of conducting inclusive research is well-established, yet recruiting a sample which reflects the distribution of a disease or condition within a target population has proven elusive for many triallists. We draw on our experiences of achieving inclusive recruitment through the intentional protocol design and delivery in the ILANA (Implementing Long-Acting Novel Antiretrovirals) study to highlight some tangible steps that could be extrapolated to trials to aid inclusive recruitment to research and produce findings which can contribute to tackling health inequities. These include the importance of meaningful public involvement from start to finish, drawing on existing data to determine appropriate targets, factoring targets into analysis plans through pre-specified analyses and triangulation with qualitative data, and making targets mandatory (rather than aspirational) through a range of strategies. We believe ILANA offers a proof of concept for triallists seeking to radically improve representation and conduct more equitable RCTs that engage all those who could benefit.</p>","PeriodicalId":23333,"journal":{"name":"Trials","volume":"26 1","pages":"229"},"PeriodicalIF":2.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12211349/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13063-025-08936-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

The importance of conducting inclusive research is well-established, yet recruiting a sample which reflects the distribution of a disease or condition within a target population has proven elusive for many triallists. We draw on our experiences of achieving inclusive recruitment through the intentional protocol design and delivery in the ILANA (Implementing Long-Acting Novel Antiretrovirals) study to highlight some tangible steps that could be extrapolated to trials to aid inclusive recruitment to research and produce findings which can contribute to tackling health inequities. These include the importance of meaningful public involvement from start to finish, drawing on existing data to determine appropriate targets, factoring targets into analysis plans through pre-specified analyses and triangulation with qualitative data, and making targets mandatory (rather than aspirational) through a range of strategies. We believe ILANA offers a proof of concept for triallists seeking to radically improve representation and conduct more equitable RCTs that engage all those who could benefit.

通过包容性方案设计实现公平招聘:来自ILANA研究的经验教训。
开展包容性研究的重要性是公认的,但事实证明,对许多试验人员来说,招募反映目标人群中疾病或病症分布的样本是难以实现的。我们利用我们在ILANA(实施长效新型抗逆转录病毒药物)研究中通过有意的方案设计和交付实现包容性招募的经验,强调可以外推到试验中的一些具体步骤,以帮助包容性招募研究并产生有助于解决卫生不平等问题的发现。其中包括从头到尾有意义的公众参与的重要性,利用现有数据确定适当的目标,通过预先指定的分析和定性数据的三角测量将目标纳入分析计划,以及通过一系列战略使目标成为强制性的(而不是愿望性的)。我们相信,ILANA为寻求从根本上改善代表性和开展更公平的随机对照试验的试验者提供了一个概念证明,使所有可能受益的人都能参与其中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Trials
Trials 医学-医学:研究与实验
CiteScore
3.80
自引率
4.00%
发文量
966
审稿时长
6 months
期刊介绍: Trials is an open access, peer-reviewed, online journal that will encompass all aspects of the performance and findings of randomized controlled trials. Trials will experiment with, and then refine, innovative approaches to improving communication about trials. We are keen to move beyond publishing traditional trial results articles (although these will be included). We believe this represents an exciting opportunity to advance the science and reporting of trials. Prior to 2006, Trials was published as Current Controlled Trials in Cardiovascular Medicine (CCTCVM). All published CCTCVM articles are available via the Trials website and citations to CCTCVM article URLs will continue to be supported.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信